• Industry stakeholders and the academia/industry interface
  • Considerations, roadmap and assays for target and off-target effects
  • Targets for VBDs: identification and structural characterization
  • Unintended side effects of pharmaceuticals on the ecosystem level
  • Promising synthetic and natural compounds against VBDs
  • Workshop: Young innovators and career development